B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

F. Hoffmann-La Roche Ltd

Celgene Corp

Johnson & Johnson

AbbVie Inc

Takeda Pharmaceutical Company Ltd

Novartis AG

Amgen Inc

GlaxoSmithKline Plc

Pfizer Inc

AstraZeneca Plc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials 35

Prominent Drugs 37

Latest Clinical Trials News on B-Cell Non-Hodgkin Lymphoma 38

Apr 13, 2017: Altor BioScience and CMC Biologics Announce Agreement for Manufacture and Validation of Altor’s IL-15 Superagonist Molecule, ALT-803, for use in Phase 3 Clinical Trials 38

Apr 06, 2017: Kite Wins 'Clinical Trial Result of the Year' for its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 Clinical and Research Excellence Awards 38

Apr 02, 2017: Kite Presents Ongoing Response Rate in Plenary Session from its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 American Association of Cancer Research Annual Meeting 39

Feb 28, 2017: Kite Announces Positive Topline Primary Results of Axicabtagene Ciloleucel from First Pivotal CAR-T Trial in Patients with Aggressive Non-Hodgkin Lymphoma 39

Clinical Trial Profile Snapshots 41

Appendix 1594

Abbreviations 1594

Definitions 1594

Research Methodology 1595

Secondary Research 1595

About GlobalData 1596

Contact Us 1596

Disclaimer 1596

Source 1597

List of Tables

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2017* 7

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2017* 13

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017* 16

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017* 21

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2017* 26

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31

B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017* 16

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017* 21

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31

B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

GlobalData Methodology 1595

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports